Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis B
NCT06289725 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2024-03-18
Summary
The study aimed to evaluate the relationship between hepatitis B virus genotype and treatment response in children with chronic hepatitis B with specific treatment indications. This is a prospective cohort study, with a follow-up period of at least 12 months, conducted at Children's Hospital 1 and City Children's Hospital, Ho Chi Minh City, Vietnam. The patient's blood was taken to be tested for hepatitis B virus genotyping using Sanger sequencing at the Center for Molecular Biomedicine Ho Chi Minh City. The research hypothesis is that genotype is related to treatment response.
Conditions
Interventions
- DRUG
-
antiviral treatment
The patient was treated with antiviral drugs according to the protocol of the Ministry of Health of Vietnam 2019
Sponsors & Collaborators
-
Ly Hoa Anh Minh
lead OTHER
Eligibility
- Min Age
- 2 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-01-01
Countries
- Vietnam
Study Locations
More Related Trials
-
Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir
NCT03236610 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
NCT02693652 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study on Antiviral Treatment of Chronic Hepatitis B in Children
NCT05792761 ·Status: RECRUITING ·Phase: NA
-
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
NCT00625560 ·Status: COMPLETED ·Phase: PHASE4
-
Stopping Antiviral Treatment in Chronic Hepatitis B
NCT04431245 ·Status: ACTIVE_NOT_RECRUITING
-
Antiviral Therapy in Infants With HBV Infection
NCT06503796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B
NCT02287857 ·Status: UNKNOWN ·Phase: NA
-
Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B
NCT07345624 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Tenofovir Combination or Mono-therapy for MDR CHB
NCT03597633 ·Status: UNKNOWN
-
Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents
NCT02337127 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B
NCT05770895 ·Status: COMPLETED ·Phase: PHASE1
-
Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
NCT03695029 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy
NCT02510963 ·Status: UNKNOWN ·Phase: NA
-
Study of Telbivudine in Chronic Hepatitis B
NCT00970216 ·Status: COMPLETED
-
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
NCT00625339 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years
NCT04565262 ·Status: UNKNOWN ·Phase: PHASE4
-
Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B
NCT02532413 ·Status: UNKNOWN ·Phase: PHASE4
-
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00412529 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)
NCT02327416 ·Status: UNKNOWN ·Phase: PHASE3
-
The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial
NCT03509688 ·Status: COMPLETED ·Phase: NA
-
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
NCT01522625 ·Status: COMPLETED ·Phase: PHASE4
-
Optimization of Antiviral Therapy of Chronic HBV Infection
NCT01623778 ·Status: COMPLETED
-
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection
NCT01480492 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment
NCT05755776 ·Status: UNKNOWN
-
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA
NCT00637663 ·Status: COMPLETED ·Phase: PHASE4